Interventional cardiology involves non-surgical procedures that treat coronary artery disease, valvular heart disease, and congestive heart failure. At MHVI, we offer a full range of diagnostic and therapeutic procedures, including diagnostic coronary angiograms, intravascular ultrasound, coronary angioplasty and stenting, as well as balloon valvuloplasty and transaortic valve replacement (TAVR).

Cardiac electrophysiology is the study and treatment of abnormal electrical heart rhythms (arrhythmia).

The Electrophysiology / Arrhythmia service at MHVI delivers the latest in diagnostic evaluations and therapeutic offerings for heart rhythm management. These include pacemaker and defibrillator implantation, devices to treat congestive heart failure, tilt table studies, electrophysiology studies, and catheter ablation for arrhythmias.

The cardiovascular surgery program at MHVI specializes in the diagnosis and surgical treatment of cardiothoracic (heart and lung) diseases. These include coronary artery disease, valvular heart disease, lung cancer, aortic aneurysms, and adult congenital heart diseases.

Peripheral vascular disease refers to diseases of the blood vessels outside the heart and brain. In patients with this disease, the arteries that carry blood to the arms, legs, brain, kidneys or stomach become narrowed or clogged, interfering with normal blood flow. This can lead to problems such as pain in your legs when walking, arm pain with activity, or even strokes.

Heart failure continues to be a large burden in the community as our patient population continues to age. Patients suffer with symptoms and debilitation with both direct and indirect costs to society. Heart failure patients have a high risk of hospital admission and readmission within 30 days of discharge. Studies have shown that multidisciplinary intervention at multiple levels have been shown to improve symptoms, decrease hospitalizations, and improve quality of life.  Metropolitan Heart and Vascular Institute (MHVI) has a comprehensive program to care for patients with congestive heart failure (CHF). 

Atrial fibrillation is the most common heart rhythm disorder (arrhythmia) in the United States, affecting 2.3 million people.  Each year, more than 5 million office visits are made for atrial fibrillation in this country.  Despite the increasing numbers of patients with this arrhythmia, there is growing confusion about how to treat atrial fibrillation amidst recent scientific and technological advancements.

Cardiac rhythm devices include pacemakers, defibrillators and loop recorders, which are implanted into patients to diagnose or treat abnormal heart rhythms or manage congestive heart failure.

The Metropolitan Heart and Vascular Institute sees thousands of patients per year for management of dose adjusted warfarin therapy. The clinic is supervised by Dr. Stephen Remole and services are directly provided by well-trained expert Registered Nurses who see patients that require blood thinning therapy.  We are a full service clinic that provides close monitoring for our patients with mechanical heart valves, heart rhythm disorders, strokes, deep venous thromboses, and pulmonary embolism.

The Lipid Clinic at the Metropolitan Heart and Vascular Institute provides effective and aggressive cholesterol management for patients with cardiovascular disease and primary lipid disorders.

The primary goal of the cardiac rehabilitation program at Metropolitan Heart and Vascular Institute is to restore patients to healthy, active living after they have suffered a cardiac event, such as a heart attack or heart failure hospitalization. Cardiac rehabilitation is a carefully planned program which is individually tailored to help people with heart disease enjoy better health through education, counseling, and exercise training.